Forte Biosciences Inc
General ticker "FBRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $39.5M
Forte Biosciences Inc does not follow the US Stock Market performance with the rate: -23.2%.
Estimated limits based on current volatility of 6.2%: low 17.26$, high 19.53$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.29$, 21.60$]
- 2024-12-30 to 2025-12-30 estimated range: [3.98$, 11.98$]
Financial Metrics affecting the FBRX estimates:
- Negative: Non-GAAP EPS, $ of -26.00 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -59.78 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term FBRX quotes
Long-term FBRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $21.49MM | $13.90MM | $32.49MM |
| Operating Income | $-21.49MM | $-13.90MM | $-32.49MM |
| Non-Operating Income | $-0.22MM | $0.02MM | $1.01MM |
| R&D Expense | $13.85MM | $5.59MM | $21.86MM |
| Income(Loss) | $-21.71MM | $-13.88MM | $-31.48MM |
| Profit(Loss) | $-21.71MM | $-13.88MM | $-31.48MM |
| Stockholders Equity | $41.55MM | $38.82MM | $35.31MM |
| Assets | $43.31MM | $42.00MM | $38.98MM |
| Operating Cash Flow | $-16.68MM | $-8.19MM | $-28.71MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.09MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $0.05MM |
| Financing Cash Flow | $-0.04MM | $7.24MM | $24.68MM |
| Earnings Per Share* | $-38.85 | $-19.96 | $-24.92 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.